These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33561034)

  • 1. Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice.
    Gaubert M; Bardin T; Cohen-Solal A; Diévart F; Fauvel JP; Guieu R; Sadrin S; Maixent JM; Galinier M; Paganelli F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 33561034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Effects of Hyperuricemia.
    Méndez Landa CE
    Contrib Nephrol; 2018; 192():8-16. PubMed ID: 29393089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum uric acid as prognostic marker of coronary heart disease (CHD).
    Purnima S; El-Aal BG
    Clin Investig Arterioscler; 2016; 28(5):216-224. PubMed ID: 27663421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of renal function in patients with newly diagnosed hypertension - the role of hyperuricemia as a risk factor for chronic kidney disease - preliminary study.
    Komendarek-Kowalska M
    Pol Merkur Lekarski; 2017 May; 42(251):193-196. PubMed ID: 28557965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
    Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
    Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.
    Mallat SG; Al Kattar S; Tanios BY; Jurjus A
    Curr Hypertens Rep; 2016 Oct; 18(10):74. PubMed ID: 27696189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
    Johnson RJ; Kivlighn SD; Kim YG; Suga S; Fogo AB
    Am J Kidney Dis; 1999 Feb; 33(2):225-34. PubMed ID: 10023633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
    Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
    Riegersperger M; Covic A; Goldsmith D
    Int Urol Nephrol; 2011 Jun; 43(2):441-9. PubMed ID: 21547469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum uric acid and the risk of hypertension and chronic kidney disease.
    Feig DI
    Curr Opin Rheumatol; 2014 Mar; 26(2):176-85. PubMed ID: 24419747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why focus on uric acid?
    Johnson RJ
    Curr Med Res Opin; 2015; 31 Suppl 2():3-7. PubMed ID: 26414730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?
    Nashar K; Fried LF
    Adv Chronic Kidney Dis; 2012 Nov; 19(6):386-91. PubMed ID: 23089273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update in uric acid, hypertension, and cardiovascular diseases.
    Kuwabara M; Kodama T; Ae R; Kanbay M; Andres-Hernando A; Borghi C; Hisatome I; Lanaspa MA
    Hypertens Res; 2023 Jul; 46(7):1714-1726. PubMed ID: 37072573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperuricemia and renal risk].
    Viazzi F; Bonino B; Ratto E; Desideri G; Pontremoli R
    G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia.
    Tsuji T; Ohishi K; Takeda A; Goto D; Sato T; Ohashi N; Fujigaki Y; Kato A; Yasuda H
    Clin Exp Nephrol; 2018 Dec; 22(6):1300-1308. PubMed ID: 29700702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperuricemia in hypertension: any clinical implication?].
    Deléaval P; Burnier M
    Rev Med Suisse; 2005 Sep; 1(32):2072-4, 2077-9. PubMed ID: 16238227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum uric acid--a cardiovasular risk factor?].
    Alderman M; Redfern JS
    Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.